DIANE YOUNG: Open Payments
NPI 1063454403 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 62 payments from 21 companies in 2025. Trend: 2023 $945 · 2024 $3,954 · 2025 $1,948
Food & beverage: $1,939Education: $9
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 12 | $447 |
| Janssen Biotech, Inc. | 5 | $275 |
| Sumitomo Pharma America, Inc. | 10 | $249 |
| IMMUNITYBIO, INC. | 3 | $204 |
| Novartis Pharmaceuticals Corporation | 4 | $127 |
| Astellas Pharma US Inc | 1 | $98 |
| TOLMAR, INC. | 3 | $75 |
| PROGENICS PHARMACEUTICALS, INC. | 3 | $71 |
| ABBVIE INC. | 4 | $68 |
| PFIZER INC. | 4 | $67 |
Products named: Nubeqa, GEMTESA, ANKTIVA, RYBREVANT, XTANDI, PLUVICTO, ERLEADA, JATENZO.
Industry payments across MD — which companies pay providers there.
